Intraprostatic inflammation is positively associated with serum PSA in men with PSA < 4 ngml-1, normal DRE and negative for prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 18, Issue 3, 2015, Pages 264-269

  Umbehr, M H ^a,b,c,d   Gurel, B ^e,f   Murtola, T J ^a,g   Sutcliffe, S ^h   Peskoe, S B ^a   Tangen, C M ⁱ   Goodman, P J ⁱ   Thompson, I M ^j   Lippman, S M ^k   Lucia, M S ^l   Parnes, H L ^m   Drake, C G ^b,e,n   Nelson, W G ^b,n   De Marzo, A M ^b,e,n   Platz, E A ^a,b,n  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TRIEMLI HOSPITAL   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f AMASYA UNIVERSITY   (Turkey)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ USA   (United States)

^j UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^m NATIONAL CANCER INSTITUTE   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CASE CONTROL STUDY; CHRONIC INFLAMMATION; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIGITAL RECTAL EXAMINATION; FEASIBILITY STUDY; HUMAN; HUMAN TISSUE; INTRAPROSTATIC INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE DISEASE; TREND STUDY; UROGENITAL TRACT INFLAMMATION; BIOPSY; BLOOD; INFLAMMATION; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84939258027     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2015.19     Document Type: Article

References (21)

1. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154: 407-413.
2. Irani J, Goujon J, Ragni E, Peyrat L, Hubert J, Saint F et al. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Urology 1999; 54: 467-472.
3. Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000; 37: 404-412.
4. Okada K, Kojima M, Naya Y, Kamoi K, Yokoyama K, Takamatsu T et al. Correlation of histological inflammation in needle biosy specimens with serum prostatespecific antigen levels in men with negative biopsy for prostate cancer. Urology 2000; 55: 892-898.
5. Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E et al. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 2003; 62: 854-859.
6. Simardi LH, Tobias-MacHado M, Kappaz GT, Taschner Goldenstein P, Potts JM, Wroclawski ER. Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 2004; 64: 1098-1101.
7. Kandirali E, Boran C, Serin E, Semercioz A, Metin A. Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology 2007; 70: 743-747.
8. Yaman O, Gogus C, Tulunay O, Tokatli Z, Ozden E. Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int 2003; 71: 160-164.
9. Gumus BH, Nese N, Gunduz MI, Kandiloglu AR, Ceylan Y, Buyuksu C. Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens. Int Urol Nephrol 2004; 36: 549-553.
10. Ozden C, Ozdal OL, Guzel O, Han O, Seckin S, Memis A. The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis. Int Urol Nephrol 2007; 39: 859-863.
11. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997; 157: 1301-1303.
12. Gurel B, Lucia MS, Thompson IM Jr, Goodman PJ, Tangen CM, Kristal AR et al. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2014; 23: 847-856.
13. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236-237.
14. Thompson I, Goodman P, Tangen C, Lucia M, Miller G, Ford L et al. The influence of finasteride on the development of prostate cancer. N Engl JMed 2003; 349: 215-224.
15. Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA et al. Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila) 2010; 3: 1523-1533.
16. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001; 87: 797-805.
17. Cuzick J. A Wilcoxon-type test for trend. Stat Med 1985; 4: 87-90.
18. Engelhardt PF, Brustmann H, Seklehner S, Riedl CR. Chronic asymptomatic inflammation of the prostate type IV and carcinoma of the prostate: is there a correlation? Scand J Urol 2013; 47: 230-235.
19. Stimac G, Reljic A, Spajic B, Dimanovski J, Ruzic B, Ulamec M et al. Aggressiveness of inflammation in histological prostatitis-correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy. Scott Med J 2009; 54: 8-12.
20. Chang SG, Kim CS, Jeon SH, Kim YW, Choi BY. Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer? Int J Urol 2006; 13: 122-126.
21. Hoekx L, Jeuris W, Van Marck E, Wyndaele JJ. Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation. Acta Urol Belg 1998; 66: 1-2.